Alfentanil



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Induction Of Anaesthesia 26.5%
Anaesthesia 17.6%
Analgesic Therapy 14.7%
General Anaesthesia 14.7%
Musculoskeletal Pain 8.8%
Product Used For Unknown Indication 5.9%
Antibiotic Prophylaxis 2.9%
Attention Deficit/hyperactivity Disorder 2.9%
Maintenance Of Anaesthesia 2.9%
Retinal Detachment 2.9%
Drug Interaction 14.3%
Dystonia 14.3%
Myotonia 14.3%
Procedural Complication 14.3%
Product Quality Issue 14.3%
Treatment Failure 14.3%
Urticaria 14.3%
Secondary
Drug Use For Unknown Indication 25.1%
Product Used For Unknown Indication 14.0%
Anaesthesia 12.8%
General Anaesthesia 9.7%
Induction Of Anaesthesia 5.6%
Pneumonia 4.9%
Analgesia 3.7%
Analgesic Therapy 3.7%
Drug Abuse 2.2%
Pain 2.2%
Varicose Vein Operation 2.2%
Musculoskeletal Pain 2.0%
Prophylaxis 2.0%
Antiphospholipid Syndrome 1.7%
Maintenance Of Anaesthesia 1.7%
In Vitro Fertilisation 1.6%
Anaesthesia Procedure 1.3%
Sensory Disturbance 1.3%
Renal Transplant 1.2%
Vitamin Supplementation 1.2%
Toxic Epidermal Necrolysis 20.0%
Anaphylactic Shock 10.0%
Toxicity To Various Agents 7.8%
Cardiac Arrest 6.7%
Myotonia 6.7%
Sinus Tachycardia 6.7%
Therapeutic Agent Toxicity 6.7%
Hypotension 5.6%
Sedation 5.6%
Premature Rupture Of Membranes 3.3%
Maternal Exposure During Pregnancy 2.2%
Myoclonus 2.2%
Procedural Hypotension 2.2%
Resuscitation 2.2%
Somnolence 2.2%
Tachycardia 2.2%
Transaminases Increased 2.2%
Upper Airway Obstruction 2.2%
Varicose Vein Operation 2.2%
Anaphylactic Reaction 1.1%
Concomitant
Product Used For Unknown Indication 22.6%
Anaesthesia 19.5%
Drug Use For Unknown Indication 11.0%
Pain 6.3%
Analgesia 6.0%
Crohn's Disease 4.7%
Premedication 4.7%
Sedation 4.0%
Induction Of Anaesthesia 3.6%
General Anaesthesia 3.1%
Prophylaxis 2.7%
Cancer Pain 1.8%
Prostate Cancer 1.5%
Staphylococcal Infection 1.5%
Convulsion 1.2%
Drug Abuse 1.2%
Drug Withdrawal Syndrome 1.2%
Preoperative Care 1.2%
Analgesic Therapy 1.1%
Antibiotic Prophylaxis 1.1%
Therapeutic Agent Toxicity 15.0%
Staring 10.0%
Rhabdomyolysis 8.3%
Tubulointerstitial Nephritis 7.5%
Scleroderma 5.0%
Vomiting 5.0%
White Blood Cell Count Increased 5.0%
Liver Function Test Abnormal 4.2%
Pancreatitis 4.2%
Tachycardia 4.2%
Toxic Epidermal Necrolysis 4.2%
Ectopic Pregnancy 3.3%
Multi-organ Failure 3.3%
Pulmonary Embolism 3.3%
Pupil Fixed 3.3%
Somnolence 3.3%
Ventricular Tachycardia 3.3%
Agitation 2.5%
Blister 2.5%
Disease Progression 2.5%
Interacting
General Anaesthesia 40.7%
Osteotomy 16.8%
Musculoskeletal Pain 8.1%
Drug Use For Unknown Indication 7.9%
Neuralgia 7.1%
Pain 5.2%
Maintenance Of Anaesthesia 3.7%
Anaesthesia 3.5%
Varicose Vein Operation 3.1%
Induction Of Anaesthesia 2.9%
Encephalopathy 0.6%
Attention Deficit/hyperactivity Disorder 0.2%
Sinus Tachycardia 51.2%
Myotonia 34.9%
No Adverse Event 7.0%
Drug Interaction 4.7%
Myoclonus 2.3%